rdf:type |
|
lifeskim:mentions |
umls-concept:C0007137,
umls-concept:C0008838,
umls-concept:C0016360,
umls-concept:C0205179,
umls-concept:C0282460,
umls-concept:C0460004,
umls-concept:C0521115,
umls-concept:C0549178,
umls-concept:C1517927,
umls-concept:C1519810,
umls-concept:C1522449
|
pubmed:issue |
4
|
pubmed:dateCreated |
1996-7-25
|
pubmed:abstractText |
To evaluate an intensive concomitant chemoradiotherapy protocol of conventional radiotherapy with intermittent cisplatin (CDDP) and continuous-infusion fluorouracil (5-FU) in unresectable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:ArmandJ PJP,
pubmed-author:BensmaineM AMA,
pubmed-author:BorelCC,
pubmed-author:CvitkovicEE,
pubmed-author:DomengeCC,
pubmed-author:EschwegeFF,
pubmed-author:GuillotTT,
pubmed-author:JankóEE,
pubmed-author:LuboinskiBB,
pubmed-author:RecondoGG,
pubmed-author:Tellez BernalEE,
pubmed-author:WibaultPP,
pubmed-author:de ForniMM
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1192-200
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8648374-Adult,
pubmed-meshheading:8648374-Aged,
pubmed-meshheading:8648374-Antimetabolites, Antineoplastic,
pubmed-meshheading:8648374-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8648374-Carcinoma, Squamous Cell,
pubmed-meshheading:8648374-Chemotherapy, Adjuvant,
pubmed-meshheading:8648374-Cisplatin,
pubmed-meshheading:8648374-Feasibility Studies,
pubmed-meshheading:8648374-Female,
pubmed-meshheading:8648374-Fluorouracil,
pubmed-meshheading:8648374-Head and Neck Neoplasms,
pubmed-meshheading:8648374-Humans,
pubmed-meshheading:8648374-Infusions, Intravenous,
pubmed-meshheading:8648374-Male,
pubmed-meshheading:8648374-Middle Aged,
pubmed-meshheading:8648374-Neoplasm Staging,
pubmed-meshheading:8648374-Patient Compliance,
pubmed-meshheading:8648374-Prognosis,
pubmed-meshheading:8648374-Radiotherapy, Adjuvant,
pubmed-meshheading:8648374-Risk Factors,
pubmed-meshheading:8648374-Survival Analysis,
pubmed-meshheading:8648374-Treatment Outcome
|
pubmed:year |
1996
|
pubmed:articleTitle |
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
|
pubmed:affiliation |
Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|